Sung Soo Yoon (Sung-Soo Yoon)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 55

Top Topics

Acute Myeloid Leukemia

Multiple Myeloma

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Journal of Korean medical science

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Hye Won Kook, Ji Eun Jang, Chang-Ki Min, Dok Hyun Yoon, Kihyun Kim, Soo-Mee Bang, Yong Park, Jae Hoon Lee, Sung Soo Yoon, Jin Seok Kim
A Multicenter Analysis of Clinical Features and Long-Term Outcomes of POEMS Syndrome in Korea. Journal of Korean medical science 39 (2) (2024)
Hye Won Kook, Ji Eun Jang, Chang-Ki Min, Dok Hyun Yoon, Kihyun Kim, Soo-Mee Bang, Yong Park, Jae Hoon Lee, Sung Soo Yoon, Jin Seok Kim
A Multicenter Analysis of Clinical Features and Long-Term Outcomes of POEMS Syndrome in Korea. Journal of Korean medical science 39 (2) (2024)
Dongchan Kim, Sheehyun Kim, Hyojin Song, Daehyeon Gwak, Suji Min, Ja Min Byun, Youngil Koh, Junshik Hong, Sung Soo Yoon, Hongseok Yun, Dong-Yeop Shin
Pursuing dynamics of minimal residual leukemic subclones in relapsed and refractory acute myeloid leukemia during conventional therapy. Cancer medicine 13 (7) (2024)
Changhee Park, Ho Sup Lee, Byung Soo Kim, Won-Sik Lee, Young Rok Do, Jae-Yong Kwak, Ho-Jin Shin, Sung-Yong Kim, Jun Ho Yi, Sung-Nam Lim, Jeong-Ok Lee, Deok Hwan Yang, Hun Jang, Byoungsan Choi, Jiwoo Lim, Choong Hyun Sun, Ja Min Byun, Sung Soo Yoon, Youngil Koh
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial. Nature communications 15 (1) (2024)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Chan Yoon Y Cheah, Connie Y Ma, Huang Huang, Antonia Kwan, Michael C Wei, Shen Yin, Nancy L Bartlett
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Chan Yoon Y Cheah, Connie Y Ma, Huang Huang, Antonia Kwan, Michael C Wei, Shen Yin, Nancy L Bartlett
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
Changhee Park, Ho Sup Lee, Byung Soo Kim, Won-Sik Lee, Young Rok Do, Jae-Yong Kwak, Ho-Jin Shin, Sung-Yong Kim, Jun Ho Yi, Sung-Nam Lim, Jeong-Ok Lee, Deok Hwan Yang, Hun Jang, Byoungsan Choi, Jiwoo Lim, Choong Hyun Sun, Ja Min Byun, Sung Soo Yoon, Youngil Koh
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial. Nature communications 15 (1) (2024)
Hye Won Kook, Ji Eun Jang, Chang-Ki Min, Dok Hyun Yoon, Kihyun Kim, Soo-Mee Bang, Yong Park, Jae Hoon Lee, Sung Soo Yoon, Jin Seok Kim
A Multicenter Analysis of Clinical Features and Long-Term Outcomes of POEMS Syndrome in Korea. Journal of Korean medical science 39 (2) (2024)
Changhee Park, Ho Sup Lee, Byung Soo Kim, Won-Sik Lee, Young Rok Do, Jae-Yong Kwak, Ho-Jin Shin, Sung-Yong Kim, Jun Ho Yi, Sung-Nam Lim, Jeong-Ok Lee, Deok Hwan Yang, Hun Jang, Byoungsan Choi, Jiwoo Lim, Choong Hyun Sun, Ja Min Byun, Sung Soo Yoon, Youngil Koh
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial. Nature communications 15 (1) (2024)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Chan Yoon Y Cheah, Connie Y Ma, Huang Huang, Antonia Kwan, Michael C Wei, Shen Yin, Nancy L Bartlett
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
Changhee Park, Ho Sup Lee, Byung Soo Kim, Won-Sik Lee, Young Rok Do, Jae-Yong Kwak, Ho-Jin Shin, Sung-Yong Kim, Jun Ho Yi, Sung-Nam Lim, Jeong-Ok Lee, Deok Hwan Yang, Hun Jang, Byoungsan Choi, Jiwoo Lim, Choong Hyun Sun, Ja Min Byun, Sung Soo Yoon, Youngil Koh
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial. Nature communications 15 (1) (2024)
Dongchan Kim, Sheehyun Kim, Hyojin Song, Daehyeon Gwak, Suji Min, Ja Min Byun, Youngil Koh, Junshik Hong, Sung Soo Yoon, Hongseok Yun, Dong-Yeop Shin
Pursuing dynamics of minimal residual leukemic subclones in relapsed and refractory acute myeloid leukemia during conventional therapy. Cancer medicine 13 (7) (2024)
Hye Won Kook, Ji Eun Jang, Chang-Ki Min, Dok Hyun Yoon, Kihyun Kim, Soo-Mee Bang, Yong Park, Jae Hoon Lee, Sung Soo Yoon, Jin Seok Kim
A Multicenter Analysis of Clinical Features and Long-Term Outcomes of POEMS Syndrome in Korea. Journal of Korean medical science 39 (2) (2024)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Chan Yoon Y Cheah, Connie Y Ma, Huang Huang, Antonia Kwan, Michael C Wei, Shen Yin, Nancy L Bartlett
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Khai Li Chai, Cameron Wellard, Ltp Thao, Naomi Aoki, Elizabeth M Moore, Bradley M Augustson, Akshay Bapat, Hilary Blacklock, Wee J Chng, Rachel Cooke, Cecily J Forsyth, Yeow-Tee Goh, Nada Hamad, Simon J Harrison, P Joy Ho, Jay Hocking, Ian Kerridge, Jin Seok Kim, Kihyun Kim, Tracy King, Georgia J McCaughan, Peter Mollee, C Orla Morrissey, Nick Murphy, Hang Quach, Xuan Ni Tan, Allison Ching Yee Tso, Kimberly Sq Wong, Sung Soo Yoon, Andrew Spencer, Erica M Wood, Zoe K McQuilten
Variation in immunoglobulin use and impact on survival in myeloma. EJHaem 5 (4) (2024)
Dong Hyun Kim, Junshik Hong, Dong-Yeop Shin, Inho Kim, Sung Soo Yoon, Soo Mee Bang, Jeong-Ok Lee, Ji Yun Lee, Sang-A Kim, Ja Min Byun, Youngil Koh
Phase II trial of posaconazole prophylaxis during anti-thymocyte globulin treatment for aplastic anaemia and hypoplastic myelodysplastic syndrome. British journal of haematology 205 (1) (2024)
Khai Li Chai, Cameron Wellard, Ltp Thao, Naomi Aoki, Elizabeth M Moore, Bradley M Augustson, Akshay Bapat, Hilary Blacklock, Wee J Chng, Rachel Cooke, Cecily J Forsyth, Yeow-Tee Goh, Nada Hamad, Simon J Harrison, P Joy Ho, Jay Hocking, Ian Kerridge, Jin Seok Kim, Kihyun Kim, Tracy King, Georgia J McCaughan, Peter Mollee, C Orla Morrissey, Nick Murphy, Hang Quach, Xuan Ni Tan, Allison Ching Yee Tso, Kimberly Sq Wong, Sung Soo Yoon, Andrew Spencer, Erica M Wood, Zoe K McQuilten
Variation in immunoglobulin use and impact on survival in myeloma. EJHaem 5 (4) (2024)
Hye Won Kook, Ji Eun Jang, Chang-Ki Min, Dok Hyun Yoon, Kihyun Kim, Soo-Mee Bang, Yong Park, Jae Hoon Lee, Sung Soo Yoon, Jin Seok Kim
A Multicenter Analysis of Clinical Features and Long-Term Outcomes of POEMS Syndrome in Korea. Journal of Korean medical science 39 (2) (2024)
Dong Hyun Kim, Junshik Hong, Dong-Yeop Shin, Inho Kim, Sung Soo Yoon, Soo Mee Bang, Jeong-Ok Lee, Ji Yun Lee, Sang-A Kim, Ja Min Byun, Youngil Koh
Phase II trial of posaconazole prophylaxis during anti-thymocyte globulin treatment for aplastic anaemia and hypoplastic myelodysplastic syndrome. British journal of haematology (2024)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Chan Yoon Y Cheah, Connie Y Ma, Huang Huang, Antonia Kwan, Michael C Wei, Shen Yin, Nancy L Bartlett
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Jin Seok Kim, Jun Ho Jang, Deog-Yeon Jo, Seo-Yeon Ahn, Sung Soo Yoon, Je Hwan Lee, Sung-Hyun Kim, Chul Won Choi, Ho Jin Shin, Min-Kyoung Kim, Jae Hoon Lee, Yeung Chul Mun, Jee Hyun Kong, BokJin Hyun, HyunSun Nam, Eunhye Kim, Min Joo Kwak, Yong Kyun Won, Jong Wook Lee
Long-Term Efficacy and Safety of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and High Disease Burden: Real-World Data From Korea. Journal of Korean medical science 38 (41) (2023)
Jung Hoon Shin, Ji Yun Lee, Gyeong-Won Lee, Won Seog Kim, Yong Park, Young Rok Do, Dea Sik Kim, Ki Hwan Kim, Yoon Seok Choi, Ja Min Byun, Junshik Hong, Inho Kim, Sung Soo Yoon, Youngil Koh
Phase II study of bortezomib, cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma. British journal of haematology (2023)
Andrew Spencer, Philippe Moreau, Maria-Victoria Mateos-Manteca, Hartmut Goldschmidt, Kenshi Suzuki, Mark-David Levin, Pieter Sonneveld, Robert Z Orlowski, Sung Soo Yoon, Saad Z Usmani, Katja C Weisel, Donna Reece, Tahamtan Ahmadi, Huiling Pei, Wendy Garvin Mayo, Xue Gai, Jodi Carey, J Blake Bartlett, Robin Carson, Meletios-Athanasios A Dimopoulos
Daratumumab in Myeloma Patients With Early or Late Relapse After Initial Therapy: Subgroup Analysis of CASTOR and POLLUX. Blood advances (2023)
Jun Liu, Suji Min, Dongchan Kim, Jihyun Park, Eunchae Park, Shanshan Pei, Youngil Koh, Dong-Yeop Shin, Ja Min Byun, Myunggon Ko, Sung Soo Yoon, Junshik Hong
Pharmacological GLUT3 salvage augments the efficacy of vitamin C-induced TET2 restoration in acute myeloid leukemia. Leukemia (2023)
Nancy L Bartlett, Sarit Assouline, Pratyush Giri, Stephen J Schuster, Chan Yoon Y Cheah, Matthew J Matasar, Gareth Peter Gregory, Dok-Hyun Yoon, Mazyar Shadman, Keith Fay, Sung Soo Yoon, Carlos Panizo, Ian W Flinn, Anna M Johnston, Francesc Bosch, Laurie H Sehn, Michael C Wei, Shen Yin, Iris To, Chi-Chung Li, Huang Huang, Antonia Kwan, Elicia Penuel, L Elizabeth Elizabeth Budde
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma. Blood advances (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Eun Hee Jung, Ja Min Byun, Dong-Yeop Shin, Young Rok Do, Jae-Cheol Jo, Sang Min Lee, Sung Soo Yoon
Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122). Cancer medicine (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Jang-Il Sohn, Min-Hak Choi, Dohun Yi, A Vipin Menon, Yeon Jeong Kim, Junehawk Lee, Jung Woo Park, Sungkyu Kyung, Seung-Ho Shin, Byunggook Na, Je-Gun Joung, Young Seok Ju, Min Sun Yeom, Youngil Koh, Sung Soo Yoon, Daehyun Baek, Tae-Min Kim, Jin-Wu Nam
Ultrafast prediction of somatic structural variations by filtering out reads matched to pan-genome k-mer sets. Nature biomedical engineering (2022)
Raymond Siu Ming Wong, İrfan Yavaşoğlu, Mohamed A Yassin, Pinar Tarkun, Sung Soo Yoon, Xie Wei, Ashraf Elghandour, Pantep Angchaisuksiri, Mehmet Ali Ozcan, Renchi Yang, Mervat Mattar, Masiur Rahman, Sara Ingles, Michael Goldbrunner, Jennifer Annika Frueh, Jun Ho Jang
Eltrombopag in patients with chronic immune thrombocytopenia in Asia-Pacific, Middle East, and Turkey: final analysis of CITE. Blood advances (2022)
Ha Young Jang, Hyun Kyung Lee, Chae Jeong Kim, Sung Soo Yoon, In-Wha Kim, Jung Mi Oh
Carfilzomib's Real-World Safety Outcomes in Korea: Target Trial Emulation Study Using Electronic Health Records. International journal of environmental research and public health 19 (20) (2022)
Alexander E Perl, Richard A Larson, Nikolai A Podoltsev, Stephen Strickland, Eunice S Wang, Ehab Atallah, Gary J Schiller, Giovanni Martinelli, Andreas Neubauer, Jorge Sierra, Pau Montesinos, Christian Recher, Sung Soo Yoon, Naoko Hosono, Masahiro Onozawa, Shigeru Chiba, Hee-Je Kim, Nahla Hasabou, Qiaoyang Lu, Ramon Tiu, Mark J Levis
Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial. Blood 139 (23) (2022)
Marina Y Konopleva, Christoph Röllig, Jamie Cavenagh, Dries Deeren, Larisa Girshova, Jürgen Krauter, Giovanni Martinelli, Pau Montesinos, Jonas A Schäfer, Oliver Gerhard Ottmann, Mario Petrini, Arnaud Pigneux, Alessandro Rambaldi, Christian Recher, Rebeca Rodriguez-Veiga, David Taussig, Norbert Vey, Sung Soo Yoon, Marion Ott, Susanne Muehlbauer, Benjamin M Beckermann, Olivier Catalani, Magali Genevray, Kirsten Mundt, Candice Jamois, Pierre Fenaux, Andrew H Wei
Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trial. Blood advances 6 (14) (2022)
Jeongeun Lee, Jean Lee, Sungwon Jeon, Jeongha Lee, Insu Jang, Jin Ok Yang, Soojin Park, Byungwook Lee, Jinwook Choi, Byung-Ok Choi, Heon Yung Gee, Jaeseong Oh, In-Jin Jang, Sanghyuk Lee, Daehyun Baek, Youngil Koh, Sung Soo Yoon, Young-Joon Kim, Jong-Hee Chae, Woong-Yang Park, Jong Hwa Bhak, Murim Choi
A database of 5305 healthy Korean individuals reveals genetic and clinical implications for an East Asian population. Experimental & molecular medicine 54 (11) (2022)
Hyun Jin Ahn, Ja Min Byun, Inho Kim, Jeonghwan Youk, Youngil Koh, Dong-Yeop Shin, Junshik Hong, Sung Soo Yoon
Eltrombopag for Post-Transplant Poor Graft Function in East Asian Patients. Journal of Korean medical science 37 (6) (2022)
Hyunkyung Park, Ja Min Byun, Sung Soo Yoon, Youngil Koh, Sock-Won Yoon, Dong-Yeop Shin, Junshik Hong, Inho Kim
Cyclophosphamide addition to pomalidomide/dexamethasone is not necessarily associated with universal benefits in RRMM. PloS one 17 (1) (2022)
Chansub Lee, Sungyoung Lee, Eunchae Park, Junshik Hong, Dong-Yeop Shin, Ja Min Byun, Hongseok Yun, Youngil Koh, Sung Soo Yoon
Transcriptional signatures of the BCL2 family for individualized acute myeloid leukaemia treatment. Genome medicine 14 (1) (2022)
Jun Ho Jang, Lily Wong, Bor Sheng Ko, Sung Soo Yoon, Katie Li, Irina Baltcheva, Prasanna Kumar Nidamarthy, Raghav Chawla, Guido Junge, Eng Soo Yap
Iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria: a 2-cohort open-label proof-of-concept study. Blood advances 6 (15) (2022)
Nuri Lee, Sung-Min Kim, Youngeun Lee, Dajeong Jeong, Jiwon Yun, Sohee Ryu, Sung Soo Yoon, Yong-Oon Ahn, Sang Mee Hwang, Dong Soon Lee
Prognostic value of integrated cytogenetic, somatic variation, and copy number variation analyses in Korean patients with newly diagnosed multiple myeloma. PloS one 16 (2) (2021)
Thierry Facon, Christopher P Venner, Nizar J Bahlis, Fritz Offner, Darrell J White, Lionel Karlin, Lofti Benboubker, Sophie Rigaudeau, Philippe Rodon, Eric Voog, Sung Soo Yoon, Kenshi Suzuki, Hirohiko Shibayama, Xiaoquan Zhang, Philip Twumasi-Ankrah, Godwin Yung, Robert M Rifkin, Philippe Moreau, Sagar Lonial, Shaji K Kumar, Paul G Richardson, Sundararajan Vincent Rajkumar
Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma. Blood 137 (26) (2021)
Hyun Kyu Kim, Su Young Son, Jae Sang Oh, Ye Na Song, Ja Min Byun, Youngil Koh, Junshik Hong, Sung Soo Yoon, Choong Hwan Lee, Dong-Yeop Shin, Man-Ryul Lee
Metabolic Profiling during Acute Myeloid Leukemia Progression Using Paired Clinical Bone Marrow Serum Samples. Metabolites 11 (9) (2021)
Eunyoung Lee, Youngil Koh, Junshik Hong, Hyeon Seok Eom, Sung Soo Yoon
Recent Clinical Update of Acute Myeloid Leukemia: Focus on Epigenetic Therapies. Journal of Korean medical science 36 (13) (2021)
Sungyoung Lee, Seulki Song, Sung Soo Yoon, Youngil Koh, Hongseok Yun
Proper Read Filtering Method to Adequately Analyze Whole-Transcriptome Sequencing and RNA Based Immune Repertoire Sequencing Data for Tumor Milieu Research. Cancers 12 (12) (2020)
Ahreum Lee, Junshik Hong, Dong-Yeop Shin, Youngil Koh, Sung Soo Yoon, Pil-Jong Kim, Hong-Gee Kim, Inho Kim, Hee Kyung Park, Youngnim Choi
Association of HSV-1 and Reduced Oral Bacteriota Diversity with Chemotherapy-Induced Oral Mucositis in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation. Journal of clinical medicine 9 (4) (2020)
Ho Sup Lee, Kihyun Kim, Seok Jin Kim, Je-Jung Lee, Inho Kim, Jin Seok Kim, Hyeon-Seok Eom, Dok Hyun Yoon, Cheolwon Suh, Ho-Jin Shin, Yeung-Chul Mun, Min Kyoung Kim, Sung-Nam Lim, Chul Won Choi, Hye Jin Kang, Sung Soo Yoon, Chang-Ki Min, null null
Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study). American journal of hematology 95 (4) (2020)
Ja Min Byun, Junshik Hong, Doyeun Oh, Ho-Young Yhim, Young Rok Do, Joon Seong Park, Chul Won Jung, Deok-Hwan Yang, Jong-Ho Won, Hong Ghi Lee, Joon Ho Moon, Yeung-Chul Mun, Deog-Yeon Jo, Jae Joon Han, Je-Hwan Lee, Jae Hoon Lee, Junglim Lee, Sung Soo Yoon
Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients: Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid Leukemia. Journal of clinical medicine 9 (7) (2020)
Sung Soo Park, Ja Min Byun, Sung Soo Yoon, Kihyun Kim, Sung Hoon Jung, Je-Jung Lee, Chang-Ki Min
Daratumumab monotherapy for relapsed/refractory multiple myeloma, focussed on clinical trial-unfit patients and subsequent therapy. British journal of haematology 193 (1) (2020)
Jayoung Ku, Ryul Kim, Dongchan Kim, Daeyoon Kim, Seulki Song, Keonyong Lee, Namseok Lee, MinA Kim, Sung Soo Yoon, Nam Hoon Kwon, Sunghoon Kim, Yoosik Kim, Youngil Koh
Single-cell analysis of AIMP2 splice variants informs on drug sensitivity and prognosis in hematologic cancer. Communications biology 3 (1) (2020)
Hyunkyung Park, Ja Min Byun, Sung Soo Yoon, Youngil Koh, Dong-Yeop Shin, Junshik Hong, Inho Kim
Allogeneic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma Treatment: Is It Still Relevant? (Running Title: The Role of Salvage alloSCT in MM). Journal of clinical medicine 9 (8) (2020)
Jung Hoon Shin, Daeyoon Kim, Hyung-Lae Kim, Murim Choi, Youngil Koh, Sung Soo Yoon
Oncogenic effects of germline variants in lysosomal storage disease genes. Genetics in medicine : official journal of the American College of Medical Genetics 21 (12) (2019)
Hae Il Cheong, Sang Kyung Jo, Sung Soo Yoon, Heeyeon Cho, Jin Seok Kim, Young Ok Kim, Ja Ryong Koo, Yong Park, Young Seo Park, Youn Ho Shin, Kee Hwan Yoo, Doyeun Oh
Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in Korea. Journal of Korean medical science 31 (10) (2017)
Jun Ho Jang, Jin Seok Kim, Sung Soo Yoon, Je Hwan Lee, Yeo Kyeoung Kim, Deog-Yeon Jo, Joo-Seop Chung, Sang Kyun Sohn, Jong Wook Lee
Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH Registry. Journal of Korean medical science 31 (2) (2016)